NCT05913024View on ClinicalTrials.gov

Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months

PHASE2CompletedINTERVENTIONAL

Enrollment

470

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

October 24, 2022

Study Completion Date

October 24, 2022

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL

Enterovirus Type 71 Vaccine

Participants received two doses of the vaccine, 28 days apart

Trial Locations (1)

410005

Hunan Provincial Center for Disease Control and Prevention, Changsha

All Listed Sponsors

lead

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

INDUSTRY

NCT05913024 - Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months | Biotech Hunter | Biotech Hunter